EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia

Borna Naderi, Brianna Davies, Habib Khan, Shubhayan Sanatani, Jason G Andrade, Matthew T Bennett, Nathaniel M Hawkins, Santabhanu Chakrabarti, John A Yeung-Lai-Wah, Marc W Deyell, Zachary W M Laksman, Thomas M Roston und 1 weitere

JACC: Clinical Electrophysiology · 2024

DOI: 10.1016/j.jacep.2024.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2024. Verfasst von Borna Naderi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Electrocardiography, Ambulatory, Tachycardia, Ventricular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Holter monitoring may raise suspicion of an underlying catecholaminergic polymorphic ventricular tachycardia (CPVT) diagnosis. Although not a primary investigation for CPVT, Holter monitoring is ubiquitously used as a diagnostic tool in the heart rhythm clinic. OBJECTIVES: The objective of this study was to explore Holter monitoring in CPVT diagnosis. METHODS: This retrospective cohort study analyzed off-therapy Holter monitoring from 13 ryanodine receptor 2-positive CPVT and 34 healthy patients from the Canadian Hearts in Rhythm Organization national registry. Using the Edwards method, the ratio of ambient-maximum heart rate during Holter monitoring was correlated with exertion level to separate premature ventricular contractions (PVCs) during periods of adrenergic and nonadrenergic stress. A receiver operating characteristic curve analysis determined the optimal threshold for isolating CPVT-induced PVCs during adrenergic states. RESULTS: PVC burden differed between groups (P = 0.001) but was within population norm, suggesting ambient PVCs are uncommon in CPVT. CPVT patients had higher PVC counts than healthy controls (P = 0.002), with a different distribution based on adrenergic state. The optimal threshold for separating PVCs into periods of adrenergic and nonadrenergic stress in CPVT patients was 76% of the maximum heart rate during the monitoring period. Compared with healthy controls, CPVT patients had a higher PVC count, limited to periods of adrenergic stress, defined by >76% maximum heart rate threshold (P = 0.002; area under the receiver operating characteristic curve: 0.84). Below this threshold, there was no significant PVC difference (P = 0.604). CONCLUSIONS: Holter monitor PVC counts alone are inadequate for CPVT diagnosis, owing to the adrenergic nature of the disease. Quantifying PVC prevalence at a heart rate threshold >76% identified CPVT with moderate sensitivity (69%) and high specificity (94%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electrocardiography, AmbulatoryTachycardia, VentricularHumansRetrospective StudiesFemaleMaleAdolescentAdultYoung AdultHeart RateVentricular Premature ComplexesChildMiddle AgedRyanodine Receptor Calcium Release ChannelPolymorphic Catecholaminergic Ventricular Tachycardia

Stichwörter der Autor:innen

Holter monitoringcatecholaminergic polymorphic ventricular tachycardiainheritedventricular arrhythmia

Substanzen

Ryanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: akrahn@mail.ubc.ca.

Förderung

  • Canadian Institutes of Health Research

Zitieren

APA

Naderi, B., Davies, B., Khan, H., Sanatani, S., Andrade, J. G., Bennett, M. T., Hawkins, N. M., Chakrabarti, S., Yeung-Lai-Wah, J. A., Deyell, M. W., Laksman, Z. W. M., Roston, T. M., & Krahn, A. D. (2024). The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.06.028

Vancouver

Naderi B, Davies B, Khan H, Sanatani S, Andrade JG, Bennett MT, et al. The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia. JACC: Clinical Electrophysiology. 2024. doi:10.1016/j.jacep.2024.06.028

BibTeX
@article{Naderi2024,
  author = {Naderi, Borna and Davies, Brianna and Khan, Habib and Sanatani, Shubhayan and Andrade, Jason G and Bennett, Matthew T and Hawkins, Nathaniel M and Chakrabarti, Santabhanu and Yeung-Lai-Wah, John A and Deyell, Marc W and Laksman, Zachary W M and Roston, Thomas M and Krahn, Andrew D},
  title = {The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  doi = {10.1016/j.jacep.2024.06.028}
}
Kostenlos starten →